Correction: Effectiveness of ixekizumab in 709 real-world patients with axial spondyloarthritis and psoriatic arthritis: a nationwide cohort study

Correction: Effectiveness of ixekizumab in 709 real-world patients with axial spondyloarthritis and psoriatic arthritis: a nationwide cohort study

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-08-01
Series:	RMD Open
Online Access:	https://rmdopen.bmj.com/content/11/3/e005806corr1.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effectiveness of ixekizumab in 709 real-world patients with axial spondyloarthritis and psoriatic arthritis: a nationwide cohort study
by: Bente Glintborg, et al.
Published: (2025-07-01)

Ixekizumab in the treatment of psoriatic arthritis
by: Yu. L. Korsakova, et al.
Published: (2024-12-01)

Comparative characteristics of axial spondyloarthritis and psoriatic arthritis with axial involvement
by: Е. Е. Gubar, et al.
Published: (2024-04-01)

Differential diagnosis of axial spondyloarthritis and psoriatic arthritis with axial involvement
by: E. E. Gubar, et al.
Published: (2025-06-01)

Similarities and differences: disentangling the intersection between axial psoriatic arthritis and axial spondyloarthritis
by: Murat Torgutalp, et al.
Published: (2025-07-01)

Effectiveness and safety of secukinumab in axial spondyloarthritis and psoriatic arthritis: A retrospective analysis of its real-world usage from India
by: Sham Santhanam, et al.
Published: (2020-01-01)

Evaluation of the possibility of axial psoriatic arthritis patients meet classification criteria for axial spondyloarthritis and ankylosing spondylitis
by: E. E. Gubar, et al.
Published: (2023-08-01)

Beyond inflammation: the molecular basis of bone remodeling in axial spondyloarthritis and psoriatic arthritis
by: Giuseppe Lopalco, et al.
Published: (2025-07-01)

Efficacy of Ixekizumab in Chinese Patients with Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Level
by: Ning Kong, et al.
Published: (2025-05-01)

Early clinical response associates with long-term outcomes with ixekizumab in radiographic axial spondyloarthritis
by: Sofia Ramiro, et al.
Published: (2024-09-01)

The efficacy of the interleukin 17 inhibitor ixekizumab in psoriatic arthritis: data from real clinical practice
by: I. M. Marusenko, et al.
Published: (2021-06-01)

Comparative analysis of the frequency of comorbid diseases in axial psoriatic arthritis and other variants of axial spondyloarthritis. Data from a hospital cohort
by: A. A. Yanushonite, et al.
Published: (2024-10-01)

Current application, possibilities, and challenges of artificial intelligence in the management of rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis
by: Emre Bilgin
Published: (2025-06-01)

Specific features of axial spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, in persons of different genders
by: A. P. Rebrov, et al.
Published: (2015-03-01)

Successful use of the interleukin-17A inhibitor (ixekizumab) in the treatment of psoriatic arthritis
by: A. M. Dadalova, et al.
Published: (2020-11-01)

Axial involvement in psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2022-12-01)

Clinical experience of using Ixekizumab in treatment of a female patient with severe psoriasis and psoriatic arthritis, resistant to the therapy
by: N. V. Kungurov, et al.
Published: (2021-06-01)

Cost-effectiveness analysis of ixekizumab versus secukinumab in patients with psoriatic arthritis and concomitant moderate-to-severe psoriasis in Spain
by: Susanne Hartz, et al.
Published: (2020-08-01)

Cycle versus swap strategy after TNFi discontinuation in psoriatic arthritis and axial spondyloarthritis: a quasi-experimental study
by: Nathan den Broeder, et al.
Published: (2025-06-01)

Gender differences in psychological features and determinates of quality of life in axial spondyloarthritis and psoriatic arthritis: a cross-sectional study
by: Branko Ristic, et al.
Published: (2025-06-01)

Involvement of the axial skeleton in psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2017-03-01)

Uveitis in patients with axial spondyloarthritis or psoriatic arthritis: a post hoc analysis from placebo-controlled phase III studies with secukinumab
by: Jan Brandt-Jürgens, et al.
Published: (2025-06-01)

Enthesitis is a clue to the diagnosis of spondyloarthritis, focus on psoriatic arthritis
by: Ye. D. Yehudina, et al.
Published: (2021-02-01)

Cost-effectiveness analysis of active psoriatic arthritis treatment with ixekizumab in adult patients in Russian Federation health care system
by: E. A. Pyadushkina, et al.
Published: (2021-02-01)

Experience in using secukinumab in patients with axial psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2020-11-01)

Comparative efficacy of tofacitinib and adalimumab in patients with psoriatic arthritis in real clinical practice. Data from the Russian nationwide register of patients with psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2021-06-01)

Impact of Delay of Treatment With Disease‐Modifying Antirheumatic Drugs in Psoriatic Arthritis: The CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
by: Philip J. Mease, et al.
Published: (2025-06-01)

Diagnostic algorithm for axial involvement in psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2025-03-01)

Men with psoriatic arthritis, rheumatoid arthritis and axial spondylarthritis have more children and at an earlier age than matched controls: results from a nationwide cohort
by: Gunnstein Bakland, et al.
Published: (2025-08-01)

Estimation of the sensitivity and specificity of ASAS criteria for peripheral spondyloarthritis in patients with early psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2015-09-01)

Long-term safety of bimekizumab in adult patients with axial spondyloarthritis or psoriatic arthritis: pooled results from integrated phase IIb/III clinical studies
by: Robert Landewé, et al.
Published: (2025-04-01)

Clinical and instrumental characteristics of axial involvement in psoriatic arthritis in real-life clinical practice
by: E. E. Gubar, et al.
Published: (2022-09-01)

Specific features of axial involvement in psoriatic arthritis: data from real clinical practice
by: E. E. Gubar, et al.
Published: (2020-09-01)

Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn’s disease: a pooled analysis of 11 317 patients across clinical trials
by: Tore K Kvien, et al.
Published: (2019-06-01)

CLINICAL PROFILE OF PATIENTS WITH EARLY AXIAL SPONDYLOARTHRITIS (RUSSIAN COHORT OF PATIENTS)
by: E. E. Gubar', et al.
Published: (2014-10-01)

Comparative characteristics of early psoriatic arthritis with and without axial skeleton injury (a subanalysis of the all-Russian registry of patients with psoriatic arthritis)
by: E. E. Gubar, et al.
Published: (2019-12-01)

Progression of axial spondyloarthritis
by: Sh. F. Erdes, et al.
Published: (2021-06-01)

«FLARES» IN AXIAL SPONDYLOARTHRITIS
by: Sh. F. Erdes
Published: (2016-07-01)

Clinical and instrumental characteristics of axial psoriatic arthritis in combination with hyperuricemia
by: Yu. L. Korsakova, et al.
Published: (2024-08-01)

Detectability of the peripheral and axial manifestations of psoriatic arthritis in patients with psoriasis in dermatological practice
by: M. N. Chamurlieva, et al.
Published: (2019-10-01)